Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

61509 1497862462HCLSReviewTaiwanJune2017.pdf
Energy Boardroom

Roche teams with Oryzon in evolving epigenetics space

08.04.2014 / Scripintelligence

Roche has bought the rights to Oryzon's class of lysine specific demethylase-1 (LSD1) inhibitors, of which the lead molecule ORY-1001 was granted orphan drug status in Europe in August last year as a treatment for acute myeloid leukemia (AML). Oryzon…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: